Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

SELL
$0.29 - $0.64 $4,272 - $9,429
-14,733 Reduced 1.01%
1,448,766 $434,000
Q4 2022

Feb 13, 2023

BUY
$0.38 - $22.5 $13,077 - $774,315
34,414 Added 2.41%
1,463,499 $570,000
Q3 2022

Nov 14, 2022

SELL
$0.73 - $23.4 $30,931 - $991,504
-42,372 Reduced 2.88%
1,429,085 $1.01 Million
Q2 2022

Aug 15, 2022

SELL
$0.66 - $1.81 $114,353 - $313,606
-173,263 Reduced 10.53%
1,471,457 $1.19 Million
Q1 2022

May 13, 2022

BUY
$1.27 - $2.47 $55,330 - $107,610
43,567 Added 2.72%
1,644,720 $2.73 Million
Q4 2021

Feb 11, 2022

BUY
$2.21 - $3.22 $58,072 - $84,611
26,277 Added 1.67%
1,601,153 $3.75 Million
Q3 2021

Nov 16, 2021

BUY
$2.8 - $3.72 $109,967 - $146,099
39,274 Added 2.56%
1,574,876 $4.9 Million
Q2 2021

Aug 16, 2021

BUY
$2.61 - $4.17 $119,676 - $191,207
45,853 Added 3.08%
1,535,602 $5.15 Million
Q1 2021

May 17, 2021

BUY
$2.91 - $4.32 $254,220 - $377,399
87,361 Added 6.23%
1,489,749 $4.63 Million
Q4 2020

Feb 16, 2021

BUY
$2.15 - $3.5 $134,441 - $218,858
62,531 Added 4.67%
1,402,388 $3.86 Million
Q3 2020

Nov 13, 2020

BUY
$2.77 - $6.17 $2.46 Million - $5.47 Million
886,729 Added 195.69%
1,339,857 $3.83 Million
Q2 2020

Aug 14, 2020

BUY
$0.87 - $3.13 $21,609 - $77,742
24,838 Added 5.8%
453,128 $1.41 Million
Q4 2019

Feb 07, 2020

BUY
$0.48 - $1.38 $109,172 - $313,869
227,442 Added 113.24%
428,290 $592,000
Q2 2019

Aug 09, 2019

BUY
$0.65 - $2.12 $113,474 - $370,101
174,576 Added 664.49%
200,848 $235,000
Q1 2019

May 14, 2019

BUY
$1.54 - $2.01 $40,458 - $52,806
26,272 New
26,272 $50,000
Q2 2018

Aug 08, 2018

SELL
$2.75 - $3.85 $160,050 - $224,070
-58,200 Closed
0 $0
Q4 2017

Jan 17, 2018

BUY
$3.29 - $5.03 $50,666 - $77,462
15,400 Added 35.98%
58,200 $249,000
Q3 2017

Nov 13, 2017

BUY
$3.15 - $4.01 $134,820 - $171,628
42,800
42,800 $165,000

Others Institutions Holding VBIV

About VBI Vaccines Inc


  • Ticker VBIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 258,256,992
  • Market Cap $5.17M
  • Description
  • VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...
More about VBIV
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.